Milwaukee-based Geno.Me has made another significant technical milestone in the development of its platform.

Founded in 2020 by Britt Gottschalk, Geno.Me has developed software that allows individuals to sell their healthcare data to researchers. The company has raised $2.6 million in capital to launch the platform that will allow researchers unprecedented access to data while empowering individuals to monetize their healthcare histories.

In its latest move, Geno.Me recently received additional security compliance certifications and integrated with one of the largest healthcare databases in the country.

Geno.Me is dedicated to ensuring the privacy of healthcare data contributors. The company has been certified as Service Organization Control Audit (SOC 2) Type 1 compliant, and are in the process of receiving their Health Insurance Portability and Accountability Act (HIPAA) compliance. SOC reports are governed by the American Institute of Certified Public Accountants (AICPA) and certify that a company has adequate cyber security measures in place to protect client data.

“I think transparency, security, and compliance are very important. Those are the big things,” said Gottschalk. “We follow strict compliances for the locked down, deidentified information pool we have.”

This high level of data security has allowed Geno.Me to gain access to electronic medical records (EMR) stored in Epic Systems. Also helpful in this effort was the legislation surrounding the 21st Century Cures Act that allows wider access to patient data.

Epic Healthcare Technology Systems, founded in 1979, is headquartered in Verona, Wisconsin. It is estimated that 78% of all healthcare patients in the United States have healthcare data stored in an Epic system. The system holds more than 305 million current patient records. By creating a software integration with the software company, Geno.Me is able to easily access all patient health records stored in Epic Systems, including the locally popular MyChart system.

With the gateway open for easy data access, Gottschalk revealed plans to begin recruiting contributors willing to anonymously share their healthcare data with researchers. Contributors are paid each time their data is used by researchers and the company is currently offering incentives, like gift cards, for new contributors.

Those interested in learning more about Geno.Me can connect with the company here